- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02731391
Clinical Research on Bowel Symptoms of Patient With Pelvic Organ Prolapse
May 26, 2021 updated by: Tan Cheng, Peking University People's Hospital
Clinical Research on Bowel Symptoms of Patients With Pelvic Organ Prolapse
To study the prevalence of bowel symptoms in patients with pelvic organ prolapse.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
200
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Beijing
-
Beijing, Beijing, China, 100044
- Recruiting
- Peking University People's Hospital
-
Contact:
- Shan Wang, doctor
- Email: iao@pkuph.edu.cn
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- The patients with stage>2 POP are recruited.The patients are all received surgeries, which include transvaginal synthetic mesh surgery, the sacral fixation, tissue repair surgery and colpocleisis.
Exclusion Criteria:
- Gestation;
- Inflammatory bowel disease;
- Slow transit constipation diagnosed by Colonic transit test;
- Unable to follow up.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Mesh repairment
patients undergoing pelvic floor Reconstruction using mesh
|
|
Active Comparator: Tradition Neoplasty
patients undergoing traditional surgical approaches
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
change in the prevalence of bowel symptoms
Time Frame: baseline,1,3,6,12 months after operation.
|
baseline,1,3,6,12 months after operation.
|
|
change in the severity of intestinal symptoms
Time Frame: baseline,1,3,6,12 months after operation.
|
assessed by Birmingham Bowel and Urinary Symptoms Questionnaire
|
baseline,1,3,6,12 months after operation.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
change in the quality of life
Time Frame: baseline,1,3,6,12 months after operation.
|
assessed by international consultation on incontinence questionnaire short form
|
baseline,1,3,6,12 months after operation.
|
length of the high-pressure zone recorded by anorectal manometry
Time Frame: baseline and 12 months after operation
|
baseline and 12 months after operation
|
|
rectoanal inhibitory reflex recorded by anorectal manometry
Time Frame: baseline and 12 months after operation
|
baseline and 12 months after operation
|
|
Rectal-Vaginal pressure interval during maximum Vasalva
Time Frame: baseline and 6 months after operation
|
Measured by Peritron manometer
|
baseline and 6 months after operation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2016
Primary Completion (Anticipated)
April 1, 2022
Study Completion (Anticipated)
May 1, 2022
Study Registration Dates
First Submitted
January 28, 2016
First Submitted That Met QC Criteria
April 1, 2016
First Posted (Estimate)
April 7, 2016
Study Record Updates
Last Update Posted (Actual)
May 28, 2021
Last Update Submitted That Met QC Criteria
May 26, 2021
Last Verified
May 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- pkuph-0103969
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bowel Symptoms
-
ProgenaBiomeRecruitingIrritable Bowel Syndrome | Irritable Bowel Syndrome With Diarrhea | Irritable Bowel Syndrome With Constipation | Irritable Bowel Syndrome Characterized by Constipation | Irritable Bowel Syndrome Mixed | Irritable Bowel Syndrome Without Diarrhea | Irritable Bowel | Irritable Bowel Syndrome Aggravated and other conditionsUnited States
-
Zhongshan Hospital Xiamen UniversityCompletedInflammatory Bowel Disease(IBD)China
-
University College, LondonUnknownInflammatory Bowel Disease (IBD)
-
4SC AGCompletedInflammatory Bowel Disease (IBD)Germany, Bulgaria, Romania
-
University of LouisvilleCompletedIrritable Bowel DiseaseUnited States
-
Ecole Professionnelle des Osteopathes du QuebecNot yet recruitingInflammatory Bowel Diseases (IBD)
-
HyGIeaCare, Inc.CompletedIrritable Bowel DiseaseUnited States
-
Spectrum Health HospitalsCompletedInflammatory Bowel Disease (IBD)United States
-
University of ViennaCompleted
-
University Hospital, MontpellierRennes University Hospital - CHU PontchaillouUnknownChronic Inflammatory Bowel DiseaseFrance
Clinical Trials on Pelvic floor reconstruction(with or without mesh)
-
Peking Union Medical College HospitalUnknown
-
Peking Union Medical College HospitalUnknownUterine Prolapse | Stage IIIChina
-
National Taiwan University HospitalUnknown
-
Norwegian University of Science and TechnologySt. Olavs Hospital; Norwegian Fund for Postgraduate Training in Physiotherapy; Fund for Cancer ResearchCompletedUrinary IncontinenceNorway
-
Ethicon, Inc.CompletedPelvic Organ ProlapseUnited Kingdom, United States, Germany, Australia
-
Cairo UniversityCompleted
-
University Hospital HeidelbergKieser Training Offenbach / Marko Babovic; Kieser Training AG Zürich / Dr....Active, not recruitingProstate Cancer | Pelvic Floor Disorders | Incontinence, Urinary | Prostate EctomyGermany
-
Ethicon, Inc.CompletedCystocele | Rectocele | EnteroceleNetherlands, France, Belgium, Germany
-
West China HospitalUnknown